Mapping binding epitopes of monoclonal antibodies targeting major histocompatibility complex class I chain-related A (MICA) with hydrogen/deuterium exchange and electron-transfer dissociation mass spectrometry

2020 ◽  
Vol 412 (7) ◽  
pp. 1693-1700 ◽  
Author(s):  
Richard Y.-C. Huang ◽  
Michelle Kuhne ◽  
Shrikant Deshpande ◽  
Vangipuram Rangan ◽  
Mohan Srinivasan ◽  
...  
Keyword(s):  
Mass Spectrometry ◽  
Electron Transfer ◽  
Monoclonal Antibodies ◽  
Major Histocompatibility Complex ◽  
Major Histocompatibility Complex Class ◽  
Electron Transfer Dissociation ◽  
Hydrogen Deuterium Exchange ◽  
Complex Class ◽  
Histocompatibility Complex ◽  
Hydrogen Deuterium

scholarly journals Analysis of phosphoinositide 3-kinase inhibitors by bottom-up electron-transfer dissociation hydrogen/deuterium exchange mass spectrometry

2017 ◽  
Vol 474 (11) ◽  
pp. 1867-1877 ◽  
Author(s):  
Glenn R. Masson ◽  
Sarah L. Maslen ◽  
Roger L. Williams
Keyword(s):  
Mass Spectrometry ◽  
Electron Transfer ◽  
Electron Transfer Dissociation ◽  
Deuterium Exchange ◽  
Hydrogen Deuterium Exchange ◽  
Exchange Mass Spectrometry ◽  
Hydrogen Deuterium ◽  
Deuterium Exchange Mass Spectrometry ◽  
Phosphoinositide 3 Kinase ◽  
Hdx Ms

Until recently, one of the major limitations of hydrogen/deuterium exchange mass spectrometry (HDX-MS) was the peptide-level resolution afforded by proteolytic digestion. This limitation can be selectively overcome through the use of electron-transfer dissociation to fragment peptides in a manner that allows the retention of the deuterium signal to produce hydrogen/deuterium exchange tandem mass spectrometry (HDX-MS/MS). Here, we describe the application of HDX-MS/MS to structurally screen inhibitors of the oncogene phosphoinositide 3-kinase catalytic p110α subunit. HDX-MS/MS analysis is able to discern a conserved mechanism of inhibition common to a range of inhibitors. Owing to the relatively minor amounts of protein required, this technique may be utilised in pharmaceutical development for screening potential therapeutics.

Sign in / Sign up

Export Citation Format

Share Document